784 related articles for article (PubMed ID: 16416353)
1. [Strontium ranelate: a novel concept for the treatment of osteoporosis].
Dimai HP
Wien Klin Wochenschr; 2005 Nov; 117(21-22):728-38. PubMed ID: 16416353
[TBL] [Abstract][Full Text] [Related]
2. Strontium ranelate in osteoporosis.
Reginster JY
Curr Pharm Des; 2002; 8(21):1907-16. PubMed ID: 12171530
[TBL] [Abstract][Full Text] [Related]
3. Strontium ranelate: a dual mode of action rebalancing bone turnover in favour of bone formation.
Marie PJ
Curr Opin Rheumatol; 2006 Jun; 18 Suppl 1():S11-5. PubMed ID: 16735840
[TBL] [Abstract][Full Text] [Related]
4. Strontium ranelate: a new paradigm in the treatment of osteoporosis.
Reginster JY; Deroisy R; Jupsin I
Drugs Today (Barc); 2003 Feb; 39(2):89-101. PubMed ID: 12698204
[TBL] [Abstract][Full Text] [Related]
5. Protelos: nonvertebral and hip antifracture efficacy in postmenopausal osteoporosis.
Adami S
Bone; 2006 Feb; 38(2 Suppl 1):23-7. PubMed ID: 16434247
[TBL] [Abstract][Full Text] [Related]
6. Effects of long-term strontium ranelate treatment on the risk of nonvertebral and vertebral fractures in postmenopausal osteoporosis: Results of a five-year, randomized, placebo-controlled trial.
Reginster JY; Felsenberg D; Boonen S; Diez-Perez A; Rizzoli R; Brandi ML; Spector TD; Brixen K; Goemaere S; Cormier C; Balogh A; Delmas PD; Meunier PJ
Arthritis Rheum; 2008 Jun; 58(6):1687-95. PubMed ID: 18512789
[TBL] [Abstract][Full Text] [Related]
7. Strontium ranelate: vertebral and non-vertebral fracture risk reduction.
Seeman E
Curr Opin Rheumatol; 2006 Jun; 18 Suppl 1():S17-20. PubMed ID: 16735841
[TBL] [Abstract][Full Text] [Related]
8. Strontium ranelate: a physiological approach for optimizing bone formation and resorption.
Marie PJ
Bone; 2006 Feb; 38(2 Suppl 1):S10-4. PubMed ID: 16439191
[TBL] [Abstract][Full Text] [Related]
9. Strontium ranelate: a novel treatment in postmenopausal osteoporosis.
Tournis S; Economopoulos D; Lyritis GP
Ann N Y Acad Sci; 2006 Dec; 1092():403-7. PubMed ID: 17308165
[TBL] [Abstract][Full Text] [Related]
10. Strontium ranelate: an increased bone quality leading to vertebral antifracture efficacy at all stages.
Ortolani S; Vai S
Bone; 2006 Feb; 38(2 Suppl 1):19-22. PubMed ID: 16455319
[TBL] [Abstract][Full Text] [Related]
11. Strontium as therapy for osteoporosis.
Marie PJ
Curr Opin Pharmacol; 2005 Dec; 5(6):633-6. PubMed ID: 16183330
[TBL] [Abstract][Full Text] [Related]
12. A new treatment for post-menopausal osteoporosis: strontium ranelate.
Rizzoli R
J Endocrinol Invest; 2005; 28(8 Suppl):50-7. PubMed ID: 16323829
[TBL] [Abstract][Full Text] [Related]
13. [Therapeutic agents for disorders of bone and calcium metabolism. Osteoporotic fracture prevention by strontium ranelate].
Nakamura T
Clin Calcium; 2007 Jan; 17(1):80-7. PubMed ID: 17211097
[TBL] [Abstract][Full Text] [Related]
14. Strontium ranelate reduces the risk of vertebral and nonvertebral fractures in women eighty years of age and older.
Seeman E; Vellas B; Benhamou C; Aquino JP; Semler J; Kaufman JM; Hoszowski K; Varela AR; Fiore C; Brixen K; Reginster JY; Boonen S
J Bone Miner Res; 2006 Jul; 21(7):1113-20. PubMed ID: 16813532
[TBL] [Abstract][Full Text] [Related]
15. Vertebral fracture risk reduction with strontium ranelate in women with postmenopausal osteoporosis is independent of baseline risk factors.
Roux C; Reginster JY; Fechtenbaum J; Kolta S; Sawicki A; Tulassay Z; Luisetto G; Padrino JM; Doyle D; Prince R; Fardellone P; Sorensen OH; Meunier PJ
J Bone Miner Res; 2006 Apr; 21(4):536-42. PubMed ID: 16598373
[TBL] [Abstract][Full Text] [Related]
16. Strontium: new drug. Postmenopausal osteoporosis: too many unknowns.
Prescrire Int; 2005 Dec; 14(80):207-11. PubMed ID: 16397977
[TBL] [Abstract][Full Text] [Related]
17. Five years treatment with strontium ranelate reduces vertebral and nonvertebral fractures and increases the number and quality of remaining life-years in women over 80 years of age.
Seeman E; Boonen S; Borgström F; Vellas B; Aquino JP; Semler J; Benhamou CL; Kaufman JM; Reginster JY
Bone; 2010 Apr; 46(4):1038-42. PubMed ID: 20026265
[TBL] [Abstract][Full Text] [Related]
18. [Strontium ranelate's (Osseor) dual mode of action: increasing bone mass and decreasing bone resorption].
Kaliterna DM
Reumatizam; 2008; 55(2):73-4. PubMed ID: 19024281
[TBL] [Abstract][Full Text] [Related]
19. Dual effect of strontium ranelate: stimulation of osteoblast differentiation and inhibition of osteoclast formation and resorption in vitro.
Bonnelye E; Chabadel A; Saltel F; Jurdic P
Bone; 2008 Jan; 42(1):129-38. PubMed ID: 17945546
[TBL] [Abstract][Full Text] [Related]
20. The effects of strontium ranelate in Asian women with postmenopausal osteoporosis.
Hwang JS; Chen JF; Yang TS; Wu DJ; Tsai KS; Ho C; Wu CH; Su SL; Wang CJ; Tu ST
Calcif Tissue Int; 2008 Nov; 83(5):308-14. PubMed ID: 18843436
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]